News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 15246

Wednesday, 03/09/2016 4:24:15 PM

Wednesday, March 09, 2016 4:24:15 PM

Post# of 20689
MNTA adds Jose-Carlos Gutiérrez-Ramos to BoD

http://finance.yahoo.com/news/momenta-pharmaceuticals-appoints-jose-carlos-210500817.html

Dr. Gutiérrez-Ramos has served as Chief Executive Officer…of Synlogic Inc., since May 2015. Previously, he served as Group Senior Vice President and global head of the BioTherapeutics Research at Pfizer, where he was responsible for more than 25 novel programs across the full spectrum of clinical development...

…Dr. Gutiérrez-Ramos held senior leadership positions at several biotech companies, including Senior Vice President and Head of R&D at Avidia Inc. and Peptimmune Inc. He began his career in the drug industry at Millennium Pharmaceuticals serving as Vice President of Inflammation Drug Discovery.

Dr. Gutiérrez-Ramos holds a Ph.D. in immunochemistry from the Autonoma University in Madrid, Spain.

This appointment fills the vacancy from the retirement of John Clark on 12/31/15 (#msg-119155708).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”